From Our Partners
Tuesday, June 28, 2022
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Biosecurity

Clinical Research Collaborations to Meet Emerging Biothreats

by Global Biodefense Staff
October 26, 2015
Llama Antibodies Could Hold Key to Marburg, Ebola Diagnostics

Credit: Shutterstock

The National Institute of Allergy and Infectious Diseases (NIAID), Division of Clinical Research (DCR), rapidly deploys administrative and technical research support services and resources to conduct time sensitive, high priority collaborative clinical research.

Fulfillment of this mission requires DCR to have the capacity to quickly facilitate collaborative clinical research both domestically and internationally.

In recent years, the NIAID research portfolio has expanded considerably in response to new challenges such as bioterrorism concerns and emerging and re-emerging infectious diseases. In response to these challenges, the DCR is anticipating additional demands for participation in special projects.

Under a new acquisition solicitation, NIAID is seeking administrative and management services support for this mission, enhancing DCR’s ability to rapidly establish collaborations with government agencies, academia, and health research entities domestically or internationally in response to urgent research demands.

Requests for projects of this nature could emanate from sources such as the U.S. Congress, U.S. State Department, Department of Health and Human Services, or the National Institutes of Health.

This requirement provides NIAID with the capacity to proactively identify and establish administrative, operational and management support services for DCR collaborative research efforts. The potential contractors role will be one of technical support and administrative, operational, and management support and oversight to investigators who develop and implement protocols.

This contract will be a Multiple Award Indefinite Quantity contract, in an amount not to exceed $750,000,000 for a contract period from April 1, 2016 through March 31, 2023.

Further details are available via Solicitation Number: NIHOA2015025. The response deadline is Dec. 7, 2015.

From Our Partners
Tags: BioterrorismNIAIDRequest for Proposals

Related Posts

Dual Use Research of Concern: NIH to Host Stakeholder Engagement Meeting on Oversight Policies
Biosecurity

Dual Use Research of Concern: NIH to Host Stakeholder Engagement Meeting on Oversight Policies

June 14, 2022
NIH to Further Invest in Point-of-Care Technologies Research Network
Biodetection

NIH to Further Invest in Point-of-Care Technologies Research Network

May 10, 2022
Hospitals Resilience to Extreme Events: One-Third of Staff May Be Lost During a Disaster
Preparedness

Hospitals Resilience to Extreme Events: One-Third of Staff May Be Lost During a Disaster

May 6, 2022
Supplemental Funding for Research at NIAID Regional Biocontainment Laboratories
Biosecurity

Supplemental Funding for Research at NIAID Regional Biocontainment Laboratories

May 5, 2022
Load More

Latest News

Poliovirus Detected in London Sewage: Response Measures Emphasize Wastewater Surveillance and Vaccination Gaps

Poliovirus Detected in London Sewage: Response Measures Emphasize Wastewater Surveillance and Vaccination Gaps

June 22, 2022
Monkeypox Diagnostics: CDC Authorizes Five Commercial Lab Companies

Monkeypox Diagnostics: CDC Authorizes Five Commercial Lab Companies

June 22, 2022
UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

June 21, 2022
Influenza Research

New Way to Identify Influenza A Virus Lights Up When Specific Virus Targets are Present

June 20, 2022

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC